Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion

Ropes & Gray has advised Novo Nordisk, and Kirkland & Ellis has advised Akero Therapeutics.Novo Nordisk has entered into a definitive agreement to acquire Akero Therapeutics,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here